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Abstract: Atopic dermatitis mainly covers the period of infancy to
adulthood, an important period in the development of an individual. The
impairmentof quality of life and thepsychologicalwellbeingof childrenwith
atopic dermatitis have been well documented but so far no data exist about
the impact of atopic dermatitis in childhood on fulfilling age-specific
developmental tasks and achieving developmental milestones during this
period, referred to as the course of life. The aims of this study were to: (i)
assess the course of life and define the disease-related consequences in
young adult patients with childhood atopic dermatitis and (ii) determine
whether the severity of atopic dermatitis is predictive for the course of life,
the disease-related consequences and quality of life later in life. Adult
patients who grew up with atopic dermatitis were asked to complete a
medical history questionnaire, the Skindex-29, the ‘‘course of life’’ ques-
tionnaire and a subjective disease-specific questionnaire. Patients with
severe atopic dermatitis in childhood showed a significant delayed social
development in their course of life. The results of the disease-specific
questionnaire demonstrated remarkable high percentages of psycho-
social consequences and physical discomfort caused by atopic dermatitis
in childhood. Patients showed a severely negative impact of atopic derma-
titis on their current quality of life. This is the first study that applied the
‘‘courseof life’’questionnaire inatopicdermatitis.More insight in thecourse
of life, disease-specific consequences andquality of life of atopic dermatitis
is of high importance, especially in case of severe atopic dermatitis.
Atopic dermatitis (AD) is a chronic relapsing,
inﬂammatory skin disease, characterized by a range of
clinical features of which pruritus and typically distrib-
uted eczematous lesions are the most essential (1–3). As
the result of a twofold to threefold increase in prevalence
during the last 3 decades, AD has become one of the
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most common childhood disorders (3–5). Despite the
proposal of diﬀerent sets of diagnostic criteria, so far no
deﬁnitive gold standard for diagnosing AD has been
accepted (6–8).
It is known that AD not only causes physical symp-
toms such as pruritus, skin discomfort, and sleep dis-
ruption, but can also lead to emotional problems and
social dysfunction. The annoying physical symptoms, as
well as the unpredictable course and intensive treatment
of the disease, can have signiﬁcant impact on the physical
and psychological wellbeing of AD patients (9). More-
over, AD patients are aﬀected not only by the disease
itself but also by the stigma associated with its visibility
(10,11). Chronic skin diseases have always had a major
negative impact on a patient’s quality of life (QoL), and
since 1987 this impact can be measured in a repeatable
standardized way (12). Several questionnaires were
developed to measure QoL in dermatology, e.g., the
Dermatology Life Quality Index, the Children’s Der-
matologyLifeQuality Index and the Skindex-29 (13–15).
Since then, the impairment ofQoLand the psychological
wellbeing of children with AD, as well as their parents,
has been well documented (16–25).
Atopic dermatitis mainly covers the period of infancy
and childhood, an important period in the development
of an individual (26). Childhood and in particular the
adolescent period is characterized not only by vitality
and rapid development, but also by vulnerability. Neg-
ative experiences, such as somatic illnesses, may have
great impact on later adult life (27). So far in literature no
attention has been paid to the long-term impact of
childhood AD. Even though suggested by other
researchers (18), no retrospective study has yet been
performed to investigate the developmental conse-
quences of growing up with AD.
Fulﬁlling age-speciﬁc developmental tasks in child-
hood as well as achieving developmental milestones in
youth, referred to as the ‘‘course of life’’ (CoL), are of
great importance to the adjustment in adult life (28–31).
In children with a chronic disease, dependence on care-
takers is frequently increased, and peer- and school-
based activities are often decreased, elements which may
aﬀect the achievement of developmental milestones. The
impact of AD in childhood on the CoL is not well
known.
A hampered CoL was found in young adults with a
history of chronic pediatric disease, such as survivors of
childhood cancer, patients with end-stage renal disease,
anorectal malformations, Hirschsprung disease, and
esophageal atresia (30,31). No knowledge exists about
the CoL of young AD patients.
The primary aimof this studywas to assess theCoL in
young adult patients growing up with AD in childhood
and compare this with that of a healthy matched control
group. Second, we will deﬁne the disease-related conse-
quences for AD patients during childhood and we will
determine whether severity of AD is predictive for the
CoL and the disease-related consequences during child-
hood.Finally, the currentQoLof thepatientswithADin
childhood is determined. AsAD continuously aﬀects the
daily life of patients, their CoL is expected to be dis-
turbed. Considering the severity of AD to be of inﬂuence
on theCoL, patientswith severeADare expected tohave
a more hampered CoL.
METHODS
Patients and Procedures
Thismono-center cross-sectional studywasperformedat
the Department of Dermatology of the Academic
Medical Center in Amsterdam, the Netherlands. By
computerized search, all patients in the age of 18 to
30 years, with AD in childhood, who visited the out-
patient clinic between January 2000 and July 2006, were
selected. Diagnosis of AD was based on the U.K.
Working Party’s diagnostic criteria for AD, namely an
itchy skin condition, and three of the following criteria:
history of involvement of skin creases, personal history
of asthma or hay fever, history of generally dry skin and
onset at younger than two years of age (8). Patients with
co-morbidity during childhoodother than asthmaor hay
fever andpatientsunable tounderstandquestionnaires in
Dutch were excluded from analysis. All eligible patients
were invited by a letter from the research physician and
the head of the Dermatology Department, in which they
were asked to participate in the study. Patients who did
not want to participate were asked to return a non-
response form. All participants signed an informed
consent form and were asked to ﬁll in the questionnaires
anonymously. After completing the questionnaires at
home, they could be returned in a freepost envelope
provided by the research physician.Nonresponders were
once contacted by phone. A control group was recruited
through general practitioners in a former study (30).
Measures
All participating patients were asked to complete a
medical history questionnaire, the Skindex-2915, a QoL
questionnaire, the CoL questionnaire and the subjective
disease-speciﬁc questionnaire.
The medical history questionnaire is an anamnestic
questionnaire concerning the medical history of the AD
patient. Fifteen questions were asked retrospectively and
19 were concerning the current situation. The items
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include patient characteristics, atopic history, family
history, course of disease and current and former
therapies. Based on the question about the severity of the
AD during childhood, severity was dichotomized into
mild to moderate (0) and severe (1). In addition to the
medical history, the Skindex-29, a dermatology-speciﬁc
questionnaire, developed to comprehensively measure
the complex eﬀects of a skin disease on a patient’s QoL,
was used. A composite score of >40 points means a
relatively serious negative impact of the skin disease on
the current QoL. To improve the support and medical
care of patients with AD, patients were asked to report
their personal needs.
The CoL questionnaire, developed by the Psychoso-
cial Department of the Emma Children’s Hospital, is
used to retrospectively assess the achievement of devel-
opmental milestones (32). It was developed to be able to
investigate the CoL of young adults, aged 18 to 30, who
grew upwith a chronic or life-threatening disease, and to
facilitate comparison with the CoL of peers without
history of disease. The items concern behavior charac-
teristics of certain ages, developmental tasks, and the
limitations children might encounter when growing up
with a chronic disease. The items are divided into ﬁve
scales: three developmental scales and two risk behavior
scales. In this study, we were interested in the three
developmental scales: autonomy development (six
items, autonomy at home and outside home, e.g., ‘‘age
of going on holidays without parents’’), psychosexual
development (four items, love and sexual relations, e.g.,
‘‘the ﬁrst time of falling in love’’), and social develop-
ment (12 items, contact with peers at school and in
leisure time, e.g., ‘‘belonging to a group of friends during
secondary school’’). A higher score on these scales
indicates the achievement of more milestones and the
accomplishment of more developmental tasks, which
can be seen as an indication of a more favorable CoL.
Apart from the ﬁve scales, the CoL questionnaire
measures socio-demographic outcomes in young adult-
hood. The validity and the test–retest reliability
(r ‡ 0.86) of theCoL scales is good (30,32,33). Except for
the autonomy scale, in which items concern diverging
aspects of autonomy, the internal consistency of the
scales is satisfactory (32). The use of scaleswithmoderate
internal consistency is acceptable for group comparison,
because internal consistency is an indication of random
error and has nothing to do with systematic error (bias)
(28). The Cronbach’s alphas in the population under
study were moderate to good as well.
The subjective disease-speciﬁc questionnaire consists
of 24 retrospective questions concerning AD-related
consequences during the primary and secondary school
period ofADpatients. This questionnairewas developed
to obtain an impression of the eﬀects of AD on the
patients’ daily lives. Item lists were developed from
clinical experience and insights of developmental psy-
chology and were based on the CoL questionnaire
domains (social en psycho-sexual functioning and
autonomy). Items were reviewed and discussed by the
team members to ensure appropriateness.
Scores were given on a ﬁve-point scale, from ‘‘never’’
(0) to ‘‘all the time’’ (5). Twelve questions concern the
primary school period and are about the disease-speciﬁc
psycho-social impact and the impact of its physical
aspects. The items concern feelings of shame, loneliness,
protectionbyparents, andcontactwith friends.The same
questions were asked about the secondary school period.
Statistical Analysis
The Statistical Package for Social Sciences (SPSS) Win-
dows version 11 was used for all analyses. First, missing
values were handled according to the guidelines given in
the manuals for the relevant questionnaires. Second,
Mann–Whitney tests and chi-squared tests were com-
pleted to compare responders and nonresponders with
regard to age andgender. For the Skindex-29, sum scores
£25, between 26 and 39 and above 40 were determined
and these sum scores were correlated with the current
AD severity using nonparametric correlation.
Student’s t-test was conducted to test group diﬀer-
ences on the CoL scales. Because the distribution of the
scores of the CoL scales was not fully normal, non-
parametric Mann–WhitneyU-tests were also performed
to improve reliability. To get insight into the within
group diﬀerences based on severity additional t-test and
Mann–Whitney U-tests were performed. Furthermore,
to gain adetailed insight into theCoLof theADpatients,
diﬀerences on item levelwere also calculated for scales on
which signiﬁcant diﬀerences between groupswere found.
Therefore, chi-squared tests were conducted at the fre-
quency distributions of the individual (dichotomized)
items.
Additional chi-squared tests were conducted at the
frequency distributions of the individual (dichotomized)
items for the disease-speciﬁc questionnaire for severity of
AD. Answers to the items on the disease-speciﬁc ques-
tionnaire were dichotomized by adding the categories
never and seldom (no) and the answers sometimes, often
and very often (yes). Items of which the impact was
reported (as yes) by >25% of the patients were consid-
ered clinically relevant. Because of the strong explorative
nature of our study, priority was given to ﬁnd phenom-
ena that exist (avoiding type I errors) rather than cor-
recting for multiple testing (avoiding type II errors).
Therefore, a signiﬁcance level p<0.05 was used.
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RESULTS
Patients
A total of 165 (60 men [36.4%] and 105 women [63.6%])
patients with AD were asked to complete the set of
questionnaires. A total of 117 patients returned their
questionnaires (response rate 71%). Of the 48 patients
who did not complete the questionnaires, 20 returned the
nonresponse form. Most of these nonrespondents
declared not to have enough time (n = 3), to be cur-
rently studying or working abroad (n = 4), not to have
suﬀered from AD during primary or secondary school
(n = 3), ornot tobe interested inparticipating (n = 10).
Twenty-eight of the 165 adults did not respond at all.
Comparing the responders to the nonresponders, the
nonresponders were younger at time of investigation
(M = 22.9; SD = 3.53; range 18–29; p < 0.05), and
the group consisted of a higher percentage of males
instead of females (54.2% vs 45.8%, p < 0.05).
The data of 117 patients could be used for the anal-
yses: 34 men (29.1%), 83 women (70.9%). Their mean
age was 23.4 years (SD = 3.2; range 18–30) and the
median age was 23 years. Characteristics of patients are
listed in Table 1. Of 108 patients, the item of severity of
AD during childhood could be used for analysis. The
distribution of severity of AD during childhood did not
diﬀer between men and women. Controls consisted of
508 respondents, 239 men (47.0%) and 269 women
(53.0%). Mean age 24.2 years (SD = 3.8, range 18.0–
30.9) (29).
Quality of Life
The results of the current QoLmeasured by the Skindex-
29 are presented in Table 2. A percentage of 48.7% of
patients with AD showed a severely negative impact of
ADon their currentQoL (critical score‡40).We found a
strong correlation between the reported disease severity
and the QoL (r = 0.518, p<0.001).
In answer to our question for the need of support and
medical care, majority of patients reported a clear need
for more information about treatment regimens (87%),
improvement of personal guidance and advice of the
physician during their treatment (85%), contact with
fellow-suﬀerers (52%),andpsychological support (68%).
Course of life
As a group, patients with AD in childhood did not diﬀer
signiﬁcantly from the control group on milestones in
developmental domains of the CoL questionnaire
(Table 3).However, within groupdiﬀerenceswere found
for severity. Patients who grew up with severe AD in
childhood showed signiﬁcant delayed social develop-
ment compared to patients who grew up with AD in
childhood (p<0.001). Besides, severe AD showed to
have a signiﬁcant delayed social development compared
with the control group (p<0.05).
The frequency tables of the individual items of the
social development scale of the CoL questionnaire show
the milestones for which patients with moderate AD in
childhood diﬀered signiﬁcantly from patients with severe
AD in childhood (Table 4). They diﬀered on six of 10
items of the social development scale. During primary
TABLE 1. Baseline Characteristics of the Atopic Dermatitis
(AD) Patients
AD patients (n = 117)
Age at study (years) 23.4 (3.2; 18–30)
Age at ﬁrst diagnosis (years) 3.4 (4.7; 0–17)
Mean duration of AD (years) 20.1 (5.8; 5–30)
Gender
Male 34 (29.1)
Female 83 (70.9)
AD at time of investigation
Yes 105 (91.3)
No 10 (8.7)
Severity of AD at time of investigation
None ⁄mild 20 (20.4)
Moderate 49 (50.0)
Severe 29 (29.6)
Severity of AD during childhood
Mild 0 (0)
Moderate 34 (29.1)
Severe 74 (63.2)
Treatment at time of investigation
Corticosteroids 68 (58.1)
Immunomodulators 28 (23.9)
Systemic therapy (e.g., prednisone) 4 (3.4)
Other health problems
Asthma 47 (42.0)
Hay fever 72 (67.9)
Conjunctivitis 78 (69.0)
Other 13 (11.3)
Family atopy
AD 44 (38.3)
Asthma 47 (40.9)
Hay fever 63 (54.8)
Values are expressed as mean (SD; range) or n (%).
TABLE 2. Outcomes of the Quality of Life (Skindex-29) for
Total Group of Atopic Dermatitis (AD) Patients and Current
Disease Severity
Total
AD
patients
None ⁄
mild
AD
Moderate
AD
Severe
AD
Total sum score ‡40 56 (48.7) 4 (22.8) 22 (48.9) 19* (82.6)
Total sum score 26–39 31 (26.5) 8 (44.4) 14 (31.1) 4* (17.4)
Total sum score £25 28 (23.9) 6 (33.3) 9 (20.0) 0* (0.0)
Values are expressed as n (%).
*Strong correlation for disease severity between QoL and current
disease severity (r = 0.518, p < 0.001).
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and secondary school, patients with severe AD in child-
hood had a lower number of friends (p<0.05; p<0.05),
anda lowerpercentageof children spent their leisure time
with their friends than patients with moderate AD in
childhood (p<0.001; p<0.01). Furthermore, patients
with severe AD in childhood less often belonged to a
groupof friends (p<0.05), and less oftenwent to a bar or
disco during secondary school than patients with mod-
erate AD (p<0.05), and, compared with their healthy
peers, patientswith severeAD less often reported to have
been member of a sports club during their primary and
secondary school period (p<0.01; p<0.001).
Disease-Speciﬁc Questionnaire
Considering the clinical relevant items (of which the
impact was reported by >25% of the patients), the
outcomes of the disease-speciﬁc questionnaire show that
TABLE 3. Comparison Between Total Group of Atopic Dermatitis (AD) Patients, Controls, and Disease Severity on the Three Scales
of the Course of Life (CoL) Questionnaire
Total AD
patients
(n = 117)
Control
group
(n = 508)
Moderate AD
(n = 34)
Severe AD
(n = 74)
Severe AD
(n = 74)
Control
group
(n = 508)
Autonomy development 9.33 (1.26) 9.45 (1.48) 9.61 (1.31) 9.15 (1.22) 9.15 (1.22) 9.45 (1.48)
Psycho-sexual development 7.25 (1.07) 7.14 (1.15) 7.36 (1.03) 7.17 (1.11) 7.17 (1.11) 7.14 (1.15)
Social development 20.78 (2.48) 20.96 (2.47) 21.97** (1.64) 20.22 (2.70) 20.22* (2.70) 20.96 (2.47)
Values are expressed as mean (SD).
*p<0.05 Mann–Whitney U-test comparison between severe AD and control group.
**p<0.001 Mann–Whitney U-test comparison between moderate and severe AD.
TABLE 4. Frequencies, Percentages, and Diﬀerences of the Social Development Scale of the Course of Life (CoL) Questionnaire
Between Moderate and Severe Atopic Dermatitis (AD), and Between Severe AD and Controls
Moderate AD Severe AD p-Value* Controls p-Value**
At least 1 year of membership in a sports club, primary school
Yes 28 (82.4) 53 (71.6) 0.23 427 (84.2) <0.01
No 6 (17.6) 21 (28.4) 80 (15.8)
No. friends in 1–3 grade, primary school
<4 5 (14.7) 26 (35.1) <0.05 187 (37.0) 0.76
4 or more 29 (85.3) 48 (64.0) 319 (63.0)
No. friends in 4–6 grade, primary school
<4 5 (14.7) 23 (31.1) 0.06 156 (30.9) 0.97
4 or more 29 (85.3) 51 (68.9) 349 (69.1)
Best friend, primary school
Yes 27 (79.4) 59 (80.8) 0.86 377 (74.0) 0.22
No 7 (20.6) 14 (19.2) 131 (25.8)
Most of time playing with…, primary school
Friends 34 (100) 54 (76.1) <0.001 436 (87.6) <0.01
Brothers and ⁄ or sisters, parents, on your own 0 (0) 17 (23.9) 62 (12.4)
At least 1 year of membership in a sports club, secondary school
Yes 22 (66.7) 36 (50.0) 0.08 373 (73.6) <0.001
No 11 (33.3) 36 (50.0) 134 (26.4)
No. friends, secondary school
<4 4 (12.1) 22 (30.1) <0.05 154 (30.4) 0.96
4 or more 29 (87.9) 51 (69.9) 352 (69.6)
Best friend, secondary school
Yes 24 (72.7) 53 (72.6) 0.59 372 (73.5) 0.87
No 9 (27.3) 20 (27.4) 134 (26.5)
Belonging to a group of friends, secondary school
Yes 31 (93.9) 55 (76.4) <0.05 403 (80.6) 0.40
No 2 (6.1) 17 (23.6) 97 (19.4)
Leisure time mainly with..., secondary school
Friends 32 (97.0) 54 (76.1) <0.01 430 (85.1) <0.05
Siblings, parents, alone 1 (3.0) 17 (23.9) 75 (14.9)
Going out to a bar or disco, secondary school
Sometimes ⁄ often 32 (94.1) 55 (77.5) <0.05 430 (84.8) 0.11
Never 2 (5.9) 16 (22.5) 77 (15.2)
Values are expressed as n (%).
*p-Value for moderate versus severe AD.
**p-Value for severe AD versus control group.
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the majority of the patients experienced negative impact
and discomfort caused by their AD during their primary
and secondary school period (Fig. 1). The majority of
patients withAD in childhood conﬁrmed theirAD led to
shame to peers during primary and secondary school:
63.6%and70.0%, respectively. Inaddition, considerable
percentages are shown with respect to avoidance of
intimacy (39.1% and 49.1%), social activities (31.5%
and 35.1%), and sports activities (34.5% and 43.2%)
during primary and secondary school. A clinical rele-
vance for school absence (25.2%) and doing things on
their own (24.3%) was shown during secondary school.
With respect to physical aspects of AD, high percentages
of discomfort during primary and secondary school are
observed; pain and itch (90.7%and88.1%), sleeplessness
(56.5% and 69.2%), physical fatigue (48.1% and
60.2%), and more eczema by stress (49.1% and 74.1%).
The results of the diﬀerences between patients with
moderateADandsevereADduringchildhoodwithin the
disease-speciﬁcquestionnairearepresented inTable 5. In
four items of the disease-speciﬁc questionnaire, those
havinghadmoderateADdiﬀeredsigniﬁcantlyfromthose
havinghad severeADduring childhood.Comparedwith
patients with moderate AD, patients with severe AD
during childhoodmore oftenmissed out on primary and
secondary schoolbecauseof suﬀering fromAD(p<0.05;
p<0.10). Patients with severe AD in childhood spent
more time on their own during their secondary school
period than patients with moderate AD (p<0.05). Fur-
thermore, resultsabout thephysicalaspectsofADduring
primary and secondary school showed that patients with
severe AD during childhood more often suﬀered from
physical fatigue than patients with moderate AD during
childhood (p<0.01; p<0.05).
Figure 1. Total percentages of atopic dermatitis (AD) pa-
tients reporting impact on the disease-specific questionnaire.
TABLE 5. Frequencies, Percentages, and Diﬀerences Between
Patients withModerate and Severe Atopic Dermatitis (AD) with
Respect to the Disease-Speciﬁc Questionnaire
Moderate AD Severe AD p-Value
Thinking about my primary school and my eczema, it led to
Conﬂicts with my parents
No 25 (78.1) 55 (75.3) 0.76
Yes 7 (21.9) 18 (24.7)
Shame to peers
No 14 (43.8) 24 (32.9) 0.29
Yes 18 (56.3) 49 (67.1)
Avoiding intimacy
No 24 (75.0) 40 (54.8) 0.05
Yes 8 (25.0) 30 (45.2)
Avoiding social activities
No 25 (78.1) 45 (64.3) 0.16
Yes 7 (21.9) 25 (35.7)
Avoiding sport activities
No 25 (78.1) 44 (60.3) 0.08
Yes 7 (21.9) 29 (39.7)
Missing school
No 29 (90.6) 52 (71.2) <0.05
Yes 3 (9.4) 21 (28.8)
Doing things on my own
No 29 (90.6) 56 (77.8) 0.12
Yes 3 (9.4) 16 (22.2)
Avoiding treatment
No 31 (96.9) 62 (84.9) 0.08
Yes 1 (3.1) 11 (15.1)
Thinking about my secondary school and my eczema, it led to
Conﬂicts with my parents
No 26 (78.8) 50 (69.4) 0.32
Yes 7 (21.2) 22 (30.6)
Shame to peers
No 11 (34.4) 18 (24.7) 0.30
Yes 21 (65.6) 55 (75.3)
Avoiding intimacy
No 21 (63.6) 32 (44.4) 0.07
Yes 12 (36.4) 40 (55.6)
Avoiding social activities
No 25 (75.8) 43 (58.9) 0.09
Yes 8 (24.2) 30 (41.1)
Avoiding sport activities
No 22 (66.7) 37 (50.7) 0.12
Yes 11 (33.3) 36 (49.3)
Missing school
No 28 (84.8) 51 (69.9) 0.10
Yes 5 (15.2) 22 (30.1)
Doing things on my own
No 29 (87.9) 50 (68.5) <0.05
Yes 4 (12.1) 23 (31.5)
Avoiding treatment
No 31 (93.9) 64 (87.7) 0.50
Yes 2 (6.1) 9 (12.3)
Thinking about my primary school and my eczema, I suﬀered from
Pain and itch
No 3 (9.7) 6 (8.3) 1.00
Yes 28 (90.3) 66 (91.7)
Sleeplessness
No 12 (38.7) 31 (43.1) 0.68
Yes 19 (61.3) 41 (56.9)
Physical fatigue
No 22 (71.0) 31 (43.1) <0.01
Yes 9 (29.0) 41 (56.9)
More eczema caused by stress
No 16 (55.2) 35 (48.6) 0.55
Yes 13 (44.8) 37 (51.4)
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DISCUSSION
This is the ﬁrst study that considered the CoL of young
adults with AD in childhood. The primary aim of this
study was the assessment of the CoL in young adult
patients who grew up with AD in comparison with age-
matched peers without AD. In our study, the CoL of
young adult patients with AD in childhood was found
not to be hampered in comparison with age and sex-
matched peers without a history of AD. Regarding the
whole group of young adult patients with a history of
AD, the samemilestones have been achievedwith respect
to autonomy development, social development and
psycho-sexual development. A clear explanation for this
cannot be given, but it can be reasoned that patients
having (severe)ADadapted their lifestyles and learned to
cope with their diﬃculties during their childhood.
When examining diﬀerences between patients varying
in disease severity, a clear diﬀerencewas demonstrated in
achieving milestones of social development between
moderateADand severeAD.Patients with severeAD in
childhood had fewer friends and spent less leisure time
with their friends during primary school and secondary
school compared with patients with moderate AD.
Comparingpatientswith severeADwith their healthy
controls, a signiﬁcant diﬀerence in social development
can be shown which appeared to be delayed for patients
with severe AD. Compared with their healthy peers,
patients growing up with severe AD less often took
membership in a sports club during their primary and
secondary school period. From a developmental psy-
chological point of view the fulﬁlling of age-speciﬁc
developmental tasks in childhood is of great importance
to the adjustment in adult life (34,35). With these results
our expectation concerning the severity of AD to be
predictive for the CoL has been conﬁrmed.
Our second aim was to deﬁne the disease-related
consequences during childhood for young AD patients.
AlthoughnohamperedCoL inyoungadult patientswith
a history of AD as a group was demonstrated, we found
that the majority of patients with AD during childhood
experienced negative impact and discomfort caused by
their AD. Results show that up to 70% of the patients
suﬀered from feelings of shame to peers during primary
and secondary school. In addition, increasing avoidance
of intimacy, social and sports activities was reported by
the patients. These results can be explained by psycho-
logical, physical, and social aspects and consequences
caused by AD. Our data are in line with former research
showing AD is related with increased risk of developing
psychological diﬃculties (e.g., shame and anger caused
by their eczema) as well as behavioral problems (e.g.,
increased dependency, fearfulness, and increased sick
leave for school-aged children with AD) (10,16,20).
Our results indicated that physical symptoms of AD
are of great impact to patients with AD during primary
and secondary school. A high percentage of patients
suﬀered from pruritus, sleeplessness, fatigue, and in-
creased eczema by stress. Pruritus resulting in sleepless-
ness is a widely mentioned problem caused by AD
(9,10,22,36). It is known that patients with AD awake
more often, sleep less through the night and report more
daytime fatigue (37,38). Fatigue has been demonstrated
to be closely related to physical symptoms of itching and
a worse clinical skin status in patients with AD, possibly
indicating that fatigue is a consequence of sleep distur-
bances because of an active disease process and high
levels of itching (37,39,40). In addition, fatigue has a
common psychological component, which results from
the perceived stress and experienced impairment of the
chronic skin condition. Furthermore, a growing number
of reports support the association between psychological
stress and skin condition in AD (41–43).
Our ﬁnal aim was to determine whether severity of
AD is predictive for the disease-related consequences
during childhood. A clear diﬀerence was demonstrated
betweenmoderate AD and severe AD in several items of
the disease-speciﬁc questionnaire. Patients with severe
AD during childhood showed more absence on primary
and secondary school and spentmore often time on their
own during their secondary school period. Furthermore,
patients with severe AD during childhood more often
suﬀered from physical fatigue than patients with mod-
erate AD during childhood. These ﬁndings underline
that the severity of AD is important in deﬁning the
disease-related consequences for young AD patients.
In addition to this, the results of the Skindex-29
showed that 49%of patients reported a severely negative
impact of AD on their current QoL. The majority of
patients reported a clear need for more information
about treatment, personal guidance, advice of the
TABLE 5. Continued
Moderate AD Severe AD p-Value
Thinking about my secondary school and my eczema, I suﬀered from
Pain and itch
Yes 5 (15.6) 8 (11.1) 0.52
No 27 (84.4) 64 (88.9)
Sleeplessness
Yes 10 (32.3) 22 (30.6) 0.86
No 21 (67.7) 50 (69.4)
Physical fatigue
Yes 18 (56.3) 25 (34.7) <0.05
No 14 (43.8) 47 (65.3)
More eczema caused by stress
Yes 8 (25.8) 19 (26.4) 0.95
No 23 (74.2) 53 (73.6)
Values are expressed as n (%).
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physician during their treatment and contactwith fellow-
suﬀerers during the childhood with AD, which clearly
indicates the importance of a personal approach to and
treatment strategy for each AD patient.
In this article, the results were described of the ﬁrst
research on the CoL in young adults who grew up with
AD. Although this study gained useful insights, several
limitations were encountered. First, concept ‘‘CoL’’ is
more comprehensive than the milestones covered by the
CoL questionnaire. The fact that the CoL is measured
retrospectively limits the range of topics. To prevent bias
caused by memory, the questions are factual and do not
go further back than to the primary school period. The
test–retest reliability has proven to be satisfactory, so we
can conclude that the retrospective reporting about
milestones is rather reliable. Second, because the ques-
tionnaires should be completed by the patients with a
history of AD themselves, another cause of bias arises. It
is likely that patients report to have achieved more
milestones than was actually the case to prove that they
have succeeded in getting over their disease. Third, the
disease-speciﬁc questionnaire is a new questionnaire
whichneedsmore validation.The ﬁnal limitation stresses
the problem of subjectivity of the disease severity in
childhood, as it was self-reported. However, strong
correlation could be shown between the self-reported
current severity and the Skindex-29, which indicates the
self-reported disease severity is rather reliable. Never-
theless, we want to point out that the outcomes of this
questionnaire are of clinical importance. In further
research, it will be worthwhile to investigate the conse-
quences of a delayed CoL for the adjustment in young
adulthood, e.g., QoL and social demographic outcomes.
Furthermore is seems important to study developmental
consequences prospectively and related to objectively
determined severity.
This study has demonstrated the importance of the
issue of CoL and disease-speciﬁc consequences during
childhood as reported by adult patients with AD in
childhood. It illustrated that adult patients with AD in
childhood as a group have achieved the same milestones
as their healthy peers. But attention has to be paid to
patients with severe AD in childhood, as they demon-
strated to have achieved fewer milestones concerning
social development. A clear notion of negative impact
and discomfort during childhood caused by AD was
proven by the outcomes of the disease-speciﬁc ques-
tionnaire. Knowledge about possible gaps in the CoL
and the disease-speciﬁc consequences could be useful in
clinical practice because it enables health care providers,
and especially dermatologists to aim for the most
favorable CoL and support of patients suﬀering from
AD, both during as well as after treatment. Especially in
cases of severe AD, dermatologists should not only be
attentive to the physical aspects but also to the psycho-
logical and social aspects of AD. In conclusion, we be-
lieve that in clinical care a systematic evaluation of
physical and psychosocial consequences in patients with
AD is warranted.
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